PRJNA862892
CAR - coupled CRISPR - Cas9 engineered universal donor T cells: Phase 1 trial of TT52CAR19 in paediatric refractory B - cell leukemia
On and off target NGS data following CRISPR Cas9 mediated disruption of TRAC and CD52 loci in primary human T cells